Adragos Pharma is pleased to announce its participation in Biotech Outsourcing Strategies (BOS) Basel 2026, taking place in Basel, Switzerland, from June 30 to July 1. As a global Contract Development and Manufacturing Organisation (CDMO), we look forward to connecting with industry leaders, biotech innovators, and potential partners to discuss how our integrated capabilities can support pharmaceutical development, manufacturing, and commercialisation.
Why Meet Adragos Pharma at BOS Basel?
Biotech Outsourcing Strategies Basel is one of the leading events for biotech and pharmaceutical outsourcing, partnering, and business development. As a trusted CDMO with a growing European footprint, Adragos Pharma is committed to delivering:
✔ End-to-end CDMO solutions — from drug development through to commercial manufacturing across 7 GMP-certified facilities in the EU, US, and Japan
✔ Aseptic fill and finish — liquid and lyophilised vials, prefilled syringes, and advanced freeze-drying for small molecules and biological products at our Jura and Maisons-Alfort sites
✔ Drug development expertise — formulation and analytical development for oral, parenteral, and topical dosage forms, including HPAPI handling, at our Athens centre with over 25 years of experience and more than 150 molecules developed
✔ Early-phase to commercial scale — clinical trial material supply, technology transfer, lifecycle management, and regulatory compliance to accompany your product throughout its entire journey
Our Commitment to Partnership
We combine multinational operational strength with personalised service. Our approach is built on co-ownership of your product’s success — from tech transfer to lifecycle management, we invest beyond standard timelines. Our established presence in Japan, the world’s most demanding market, demonstrates our adaptability, commitment to quality, and long-term vision.
Meet Our Team at BOS Basel 2026
Our experienced team of business development and strategic project leaders will be attending throughout the event. We invite you to connect and explore how Adragos Pharma can support your next project.
Meet our Team
Sofiane Borsla
Business Development Manager
Sofiane brings extensive experience in business development, market access, and commercial strategy across the pharmaceutical and biotech sectors. With a Master’s in Chemistry and an MBA in Biotechnology & Pharmaceutical Management, he identifies and pursues new business opportunities, combining technical expertise with strategic commercial insight to drive business expansion at Adragos Pharma.
Meet our Team
Barbara Ruggiero
Business Development Director
Barbara brings more than 20 years of experience in the pharmaceutical industry with deep expertise in pharmaceutical services sales. At Adragos Pharma, she focuses on fill and finish services for early-phase projects at our Jura and Maisons-Alfort sites, supporting customers throughout the entire development of their product for both small molecules and biological products.
Meet our Team
Marie-Sophie Quittet
Head of Strategic Projects, Jura
Marie-Sophie holds both a Doctor of Pharmacy (PharmD) and a Doctor of Philosophy (PhD), showcasing her expertise in the pharmaceutical industry. With over a decade of experience spearheading clinical production projects in Europe and the US, she brings strategic leadership in implementing clinical and commercial projects at our Jura facility.
Connect with Us in Basel
Our team will be attending Biotech Outsourcing Strategies (BOS) Basel 2026, and we welcome the opportunity to engage in discussions on potential collaborations, outsourcing solutions, and strategic partnerships. If you are attending, we invite you to connect with us during the event.
📅 June 30 – July 1, 2026
📍 Basel, Switzerland
We look forward to productive discussions and new opportunities to drive innovation in pharmaceutical development and manufacturing.
